Literature DB >> 21923452

Estimating creatinine clearance: a meta-analysis.

Sheila M Wilhelm1, Pramodini B Kale-Pradhan.   

Abstract

STUDY
OBJECTIVES: To determine which body weight descriptor most accurately predicts measured creatinine clearance (Cl(cr)) and whether rounding serum creatinine concentration (S(cr)) to 1 mg/dl when it is less than 1 mg/dl accurately predicts measured Cl(cr).
DESIGN: Meta-analysis of 13 English-language trials comparing 24-hour measured Cl(cr) with Cockcroft-Gault estimated Cl(cr) by using various body weights or rounded S(cr) values. PATIENTS: A total of 1197 patients (mean age 53.3 yrs, 48.7% male) were included in the meta-analysis.
MEASUREMENTS AND MAIN RESULTS: A thorough literature search of the PubMed, MEDLINE, and the Cochrane Library databases was performed (1976-June 2010) to identify relevant clinical trials. Patient population, number of subjects, age, and 24-hour measured and estimated Cl(cr) were extracted independently by two investigators by using standardized data collection forms. Mean difference (MD) between estimated and measured Cl(cr) was assessed. Thirteen studies met all selection criteria. A random-effects model was applied secondary to a high level of heterogeneity among the studies (I(2)>50%). Total body weight in the Cockcroft-Gault equation overestimated measured Cl(cr) (MD 15.91 ml/min, 95% confidence interval [CI] 7.17-24.65 ml/min). Ideal body weight underestimated Cl(cr) (MD-5.15 ml/min, 95% CI -9.92 to -0.38 ml/min). No body weight (i.e., assumes body weight is 72 kg, thus removing the factor of 72 from the denominator of the equation) closely estimated Cl(cr) (MD 0.43 ml/min, 95% CI -5.42-6.27 ml/min). Adjusted body weight with correction factors of 0.3 or 0.4 also closely estimated Cl(cr) (MD 4.55 ml/min, 95% CI -11.41-20.50 ml/min, and MD 19.94 ml/min, 95% CI -9.6-49.49 ml/min, respectively). Total body weight with a rounded S(cr) value closely estimated measured Cl(cr) (MD 3.51 ml/min, 95% CI -17.18-24.20 ml/min). Ideal body weight with a rounded S(cr) value underestimated Cl(cr) (MD -29.45 ml/min, 95% CI -48.46 to -10.43).
CONCLUSION: Using the Cockcroft-Gault equation with no body weight and actual S(cr) value most closely estimated measured Cl(cr). In obese patients, it may be reasonable to use actual body weight with a correction factor of 0.3 or 0.4 and actual S(cr) value in the Cockcroft-Gault equation. Based on this analysis, the use of total body weight, ideal body weight, and a rounded S(cr) value cannot be recommended.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21923452     DOI: 10.1592/phco.31.7.658

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  23 in total

1.  Acute kidney injury in patients treated with vancomycin and piperacillin-tazobactam: A retrospective cohort analysis.

Authors:  W Cliff Rutter; Donna R Burgess; Jeffery C Talbert; David S Burgess
Journal:  J Hosp Med       Date:  2017-02       Impact factor: 2.960

2.  Peak Measurement for Vancomycin AUC Estimation in Obese Adults Improves Precision and Lowers Bias.

Authors:  Manjunath P Pai; Joseph Hong; Lynne Krop
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

3.  Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.

Authors:  W Cliff Rutter; Jessica N Cox; Craig A Martin; Donna R Burgess; David S Burgess
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

4.  Appropriateness of direct oral anticoagulant dosing for venous thromboembolism treatment.

Authors:  Emmeline Tran; Ashley Duckett; Sarah Fisher; Nicole Bohm
Journal:  J Thromb Thrombolysis       Date:  2017-05       Impact factor: 2.300

5.  Association between renal function and chemotherapy-related toxicity in older adults with cancer.

Authors:  Lindsay L Peterson; Arti Hurria; Tao Feng; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Ilya Glezerman; Vani Katheria; Laura Zavala; David D Smith; Can-Lan Sun; William P Tew
Journal:  J Geriatr Oncol       Date:  2016-11-14       Impact factor: 3.599

6.  Acute Kidney Injury in Patients Treated with IV Beta-Lactam/Beta-Lactamase Inhibitor Combinations.

Authors:  W Cliff Rutter; David S Burgess
Journal:  Pharmacotherapy       Date:  2017-04-20       Impact factor: 4.705

7.  The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.

Authors:  Nicholas R Nelson; Kathryn A Morbitzer; J Dedrick Jordan; Denise H Rhoney
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

8.  Nephrotoxicity in Patients with or without Cystic Fibrosis Treated with Polymyxin B Compared to Colistin.

Authors:  Ryan L Crass; W Cliff Rutter; Donna R Burgess; Craig A Martin; David S Burgess
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

9.  Influence of β-Lactam Infusion Strategy on Acute Kidney Injury.

Authors:  Sarah E Cotner; W Cliff Rutter; Donna R Burgess; Katie L Wallace; Craig A Martin; David S Burgess
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

10.  Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.

Authors:  W Cliff Rutter; David S Burgess
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.